Dr.anne Galy
Research director
pharmaceutical
Genethon
France
Biography
Dr.Anne Galy is currently head of Inserm Unit 951 at Genethon in Evry. She has received a Doctorate in Pharmacy and a PhD in Immunology at the University of Lyon France, respectively in 1985 and 1989. In the early 1990's, she trained in Palo Alto, California as a post-doctoral fellow at DNAX research institute (with H. SPits) and worked as a scientist at SySTEMix Inc. also in Palo Alto, prior to joining Wayne State University in Detroit, Michigan where, in 2001, she became a tenured Associate Professor at the School of Medicine and Barbara Ann Karmanos Cancer Institute. Dr. Galy was recruited at Inserm, the French National Medical Research Institute where she holds a permanent position as Director of Research.
Research Interest
Dr. Galy's laboratory is interested in the gene-modification of the immune and blood system for therapeutic applications.multi-disciplinary program established at Genethon, Dr. Galy is developing treatments for primary immune and blood genetic diseases by stable gene-modification of hematopoietic stem cells. Currently, international clinical trials are conducted to test a lentiviral vector for the gene therapy of Wiskott Aldrich Syndrome.
